Nearly 4 out of 5 Canadians believe that the use of psilocybin, the active ingredient in hallucinogenic mushrooms, is an acceptable medical approach to treat ex
A new study out of Université Laval suggests blocking inflammation could reduce symptoms in some patients living with ALS, also known as Lou Gehrig's disease.
Dr Miriam Stoppard on the news that newly identified genes linked to breast cancer could eventually be included in tests to pinpoint women with an increased risk of the disease